Beam Therapeutics BEAM
NASDAQ BEAM
$24.05 -0.51 (-2.08%)
At close: Oct 23, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Sale and Maturity of Investments (2019 - 2026)

Updated

Analysis

Beam Therapeutics (BEAM) Sale and Maturity of Investments (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Beam Therapeutics 2.48 Bn -2.20 Bn - 173.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 173.00 Mn
Mar 31, 2026 181.29 Mn
Dec 31, 2025 218.03 Mn
Sep 30, 2025 240.64 Mn
Jun 30, 2025 166.67 Mn
Mar 31, 2025 217.15 Mn
Dec 31, 2024 129.25 Mn
Sep 30, 2024 183.00 Mn
Jun 30, 2024 223.93 Mn
Mar 31, 2024 144.22 Mn
Dec 31, 2023 154.96 Mn
Sep 30, 2023 271.43 Mn
Jun 30, 2023 365.53 Mn
Mar 31, 2023 298.00 Mn
Dec 31, 2022 360.09 Mn
Sep 30, 2022 333.64 Mn
Jun 30, 2022 350.57 Mn
Mar 31, 2022 160.31 Mn
Dec 31, 2021 106.35 Mn
Sep 30, 2021 260.40 Mn
API Access

Beam Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=BEAM&period=max&api_key=YOUR_API_KEY